Effect of Rizatriptan and Other Triptans on the Nausea Symptom of Migraine: A Post Hoc Analysis - Lipton, Richard B.; Pascual, Julio; Goadsby, Peter J.; Massiou, Helene; McCarroll, Kathleen A.; Vandormael, Kristel; Jiang, Kaihong; Lines, Christopher R. (Headache, 2001)
Keywords: 5-HT1B/1D receptor agonists; Administration, Oral; Adult; baseline; Biological and medical sciences; Cardiovascular system; Double-Blind Method; emergent; Humans; Indoles - adverse effects; Indoles - therapeutic use; Medical sciences; migraine; Migraine Disorders - complications; Migraine Disorders - drug therapy; naratriptan; nausea; Nausea - chemically induced; Nausea - drug therapy; Nausea - etiology; Oxazolidinones - adverse effects; Oxazolidinones - therapeutic use; Pharmacology. Drug treatments; Piperidines - adverse effects; Piperidines - therapeutic use; Randomized Controlled Trials as Topic; rizatriptan; Serotonin Receptor Agonists - adverse effects; Serotonin Receptor Agonists - therapeutic use; sumatriptan; Sumatriptan - adverse effects; Sumatriptan - therapeutic use; Triazoles - adverse effects; Triazoles - therapeutic use; Tryptamines; Vasoconstrictor Agents - adverse effects; Vasoconstrictor Agents - therapeutic use; Vasodilator agents. Cerebral vasodilators; zolmitriptan; Headache; Agonist; Sumatriptan; Zolmitriptan; Cardiovascular disease; 5-HT1 Serotonine receptor; Serotonine receptor; Vascular disease; Pain; Neurological disorder; Cerebrovascular disease; Human; Nervous system diseases; Antimigrainous agent; Migraine; Oral administration; Nausea; Biological activity; Cerebral disorder; Chemotherapy; Treatment; Central nervous system disease; Rizatriptan; Comparative study; Naratriptan